Events

IATDMCT 2013 13th International Congress of TDM & Clinical Toxicology
September 22 – 26, 2013
Salt Lake City, USA



 12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Login

Forgot Password

Our aims are:

  • Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

  • Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

  • Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

  • Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

  • Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.


Application form (PDF

Definition of TDM


IATDMCT Needs You! - Click here!

Journal

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

Latest News

Join us on LinkedIn                     Follow us on Twitter

  • IATDMCT Congress Promotional Slide
    A promotional slide for the IATDMCT Congress is available to include in your presentations to potential attendees. Click here to download.

  • Member and Journal Award
    Developing Country members are encouraged to consider seeking nominations for the awards which include a free membership and TDM journal subscription. Deadline for nomination: October 31 of 2013 for the 2014 subscription.

  • Members invited to apply to host the 2014 International Travelling Lectureship
    The Lectureship can include visits to multiple cities (2-3) or could be part of a regional meeting, depending on the country and circumstances. Members have the opportunity to offer to host the lectureship and the selected host will be responsible for the local arrangements. Click here for more information.

  • March 2013 Compass Now Available in Multiple Formats
    Busy at national or international conferences, travelling for business!!! Compass is now available in formats compatible with Kindles / Smart Phone / Tablets and can be downloaded from the IATDMCT website (click here). Try it and give your feedback to maria.shipkova@arcor.de. Enjoy reading!

  • New Job vacancy in the Members-only pages
  • NEW!  Guidelines and application form to receive permission to hold your regional meeting under the auspices of IATDMCT can be found under menu item Meetings/Regional Meetings

  • NEW!  A limited number of regional meetings will receive support from IATDMCT in the form of provision and travel support for speakers.  Guidelines and the application form can be found under Meetings/Regional Meetings  
  • Members who are presenting at a conference should visit the IATDMCT Members Only section. There is a new page "IATDMCT Promotion" with a PowerPoint presentation, and other materials that can be taken to the conference to generate membership in IATDMCT.

  • Update of a review on new TDM assays, described in literature, based on dried blood spot methods.

  • New report from the Biomarker working group (BWG) within the Immunosuppressive Committee
  • Deuterated internal standards

  • Members pages are only accessible to members who have paid their dues.
    They contain the directory of members, monographs on digoxin, theophyllin, cyclosporin and tacrolimus, the newsletters and two articles on Busulfan monitoring by L. Langman and Pharmacogenomics for Clinical and Forensic Toxicology. An Adjunct for Interpretation of Drug Toxicity by Shi et al.

    P.O. Box 1570, 4 Cataraqui Street,

    Suite 310, Kingston, Ontario K7L 5C8 Canada,
    Tel: 613-531-8166 • Fax: 1-866-303-0626
    E-mail:
    office@iatdmct.org

Powered By Dragonfly IT Ltd.